Locations:
Search
Combining advanced imaging with targeted therapy in prostate cancer and neuroendocrine tumors
Despite wide variations in contours, researchers find AI and physician methods yield equivalent results.
AI histologic classifier reliably predicts clinical risk in men post-prostatectomy
Historic collaboration connects two Cleveland Clinic locations, enables real-time sharing of metrics and surgical progress
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Patient factors and cancer characteristics are key to deciding between focal therapies and whole gland treatment
Correlation found between the biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy
Transperineal ultrasound a viable, non-invasive option for monitoring intra-fractional prostate motion
Optimized models can personalize predictions for patients with prostate, breast and other cancers
A newer modality for select patients has shown positive outcomes to date
Can genomic classifiers contemporize stratification?
Advertisement
Advertisement